Ryan Young, MD
Ophthalmology · Austin, TXNPI 1902127947
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $101,595 of the $105,360 with a category attached, or 96.4%. Baxter Healthcare accounts for 96.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $54,968 and has fallen 98.7% since, to $722 in 2025. Among ophthalmology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $1097.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$102K
- Regeneron Healthcare Solutions, Inc.$524
- AbbVie$505
- Johnson & Johnson Surgical Vision, Inc.$381
- Genentech USA, Inc.$356
- Apellis Pharmaceuticals, Inc.$280
- plus $2K from 15 others
Across 7 payments — averaging $5696.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerie Pharmaceuticals, Inc.$40K
What the payments were for
- Consulting fees$101,59596%
- Speaking & faculty fees$1500%
- Food & beverage$3,4393%
- Gifts$1760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 24 | $101,595 |
| Regeneron Healthcare Solutions, Inc. | 12 | $524 |
| AbbVie(2 entities) | 9 | $505 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $381 |
| Genentech USA, Inc. | 13 | $356 |
| Apellis Pharmaceuticals, Inc. | 6 | $280 |
| Novartis | 5 | $275 |
| Biotissue Holdings Inc. | 2 | $205 |
| Heidelberg Engineering, Inc. | 1 | $184 |
| Carl Zeiss Meditec, Inc. | 1 | $176 |
| Welch Allyn | 1 | $150 |
| Tarsus Pharmaceuticals, Inc. | 1 | $125 |
| Mallinckrodt Enterprises LLC | 1 | $119 |
| Kala Pharmaceuticals, Inc. | 1 | $103 |
| Optovue, Inc. | 1 | $100 |
| Astellas Pharma US Inc | 4 | $99 |
| Harrow Eye, LLC | 1 | $48 |
| Biogen | 3 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $43 |
| Alimera Sciences, Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hillrom - RetinaVue 700 Imager$101,595
- Hillrom - RetinaVue Network$101,595
- OZURDEX$235
- EYLEA HD$230
- Spectralis$184
- CLARUS$176
- RetinaVue Network$150
- Tecnis Simplicity$122
- Tecnis IOL$122
- VABYSMO$122
- EYLEA$122
- ACTHAR$119
- One Series Ultra$112
- Humira$110
- Prokera$106
- AmnioGraft$106
- AmnioGuard$106
- INVELTYS$103
- Tecnis Multifocal Family of 1-piece IOLS$101
- XR$100
How this compares
$105,360 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 57 | $1,929 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 126 | $1,393 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 11 | $957 |
| Ketorolac Tromethamine | 22 | $714 |
| Dorzolamide Hcl | 12 | $243 |
| Timolol Maleate | 23 | $239 |
| Latanoprost | 45 | $214 |
| Acyclovir | 12 | $128 |
| Brimonidine Tartrate | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Austin
- Chirag JhaveriAustin$240K
- Sheila BarbarinoAustin$232K
- Aaron RollerAustin$202K
- Philip StoreyAustin$161K
- Robert WongAustin$113K
- Farhan IrshadAustin$111K
- Edward WoodAustin$110K
- Steven DellAustin$94K
- Shelley GhafooriAustin$73K
- Michael SingerSan Antonio$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.